Levothyroxine is the most prescribed medication in the United States, used by millions for hypothyroidism and thyroid hormone replacement. Generic levothyroxine is available on the lowest tier of all insurance formularies at minimal cost. Brand-name versions (Synthroid, Levoxyl, Tirosint) cost more and may require step therapy to access.
Key Facts
Check Your Specific Plan's Formulary
Coverage varies by plan. Use our formulary checker tool to look up your exact copay and restrictions.
Open Formulary CheckerFrequently Asked Questions
Most plans cover both, but generic levothyroxine is on a lower tier with a lower copay. If your doctor prescribes Synthroid specifically, your plan may require trying generic first (step therapy) or charge a higher copay. Some endocrinologists prefer brand-name for consistency, and your doctor can request a formulary exception.
Some plans offer levothyroxine at $0 copay, especially ACA marketplace plans. Even plans with a copay rarely charge more than $5 to $10 for generic levothyroxine. Without insurance, pharmacy discount programs offer it for $4 to $10 per month.
While all levothyroxine products contain the same hormone, the FDA does not consider all brands therapeutically equivalent. Switching brands may require dose adjustment and monitoring. If you switch, your doctor should recheck your TSH levels in 6 to 8 weeks. Discuss any brand change with your endocrinologist.
Related Resources
- UnitedHealthcare Formulary 2026
- Blue Cross Blue Shield Formulary 2026
- Medicare Part D Formulary 2026
- Synthroid cash price comparison on RxGrab
- Tirosint cash price comparison on RxGrab
- Armour Thyroid cash price comparison on RxGrab
- Cytomel cash price comparison on RxGrab
- NP Thyroid cash price comparison on RxGrab
- Synthroid patient assistance program
- Tirosint patient assistance program
- Armour Thyroid patient assistance program
- Drug interaction checker tool
- Patient assistance program finder
Get Formulary and Coverage Updates
Subscribe to receive alerts on formulary changes, new drug approvals, and insurance coverage updates.